Role of probiotics in the management of cisplatin-induced nephrotoxicity

Abstract

New research shows that gut microbes have a role in the management of cisplatin-induced nephrotoxicity, with underlying processes involving mucosal and/or systemic inflammation or metabolic abnormalities. However, the gut microbiota profile in cisplatin-related nephrotoxicity patients has not been fully investigated. Databases were rigorously reviewed for investigations contrasting the gut microbial profiles on effective probiotics against cisplatin-induced nephrotoxicity from 1998 to 2023. Cisplatin's use is often restricted due to adverse effects like nephrotoxicity, ototoxicity, neurotoxicity, and vomiting. Probiotics, or gut microbiota, are crucial for maintaining health and treating diseases, particularly kidney damage. The current study reviewed that patients with cisplatin-induced nephrotoxicity can be protected by using supplementation of probiotics. Scientific research has focused on the active participation of natural supplementation on cisplatin-induced nephrotoxicity issues. Different preclinical studies showed that the probiotics treat cisplatin-induced nephrotoxicity, but further clinical tests are needed for full confirmation.